Department of Ophthalmology, West China Hospital of Sichuan University, Chengdu, Sichuan, China.
Department of Ophthalmology, The 3rd Affiliated Hospital of Chengdu Medical College, Pidu District People's Hospital, Chengdu, China.
Front Endocrinol (Lausanne). 2024 Oct 3;15:1434155. doi: 10.3389/fendo.2024.1434155. eCollection 2024.
Significant individual differences exist in the clinical manifestations of thyroid-associated ophthalmopathy (TAO). Age and gender have an impact on the presentation and severity of TAO.
To evaluate the clinical characteristics of TAO patients, with particular consideration of their age and gender.
Demographic and clinical data of 2479 TAO patients were collected. Patients were divided into 7 groups based on age: Group 1: ≤18 years old; Group 2: 19-29 years old; Group 3: 30-39 years old; Group 4: 40-49 years old; Group 5: 50-59 years old; Group 6: 60-69 years old; Group 7: ≥70 years old. Compared clinical manifestations among different groups and between males and females.
In age group 1, the ratio of female to male TAO patients was 3.79, and in age group 7, it was 0.86. As age increased, there was a decline in the percentage of females (γ=-0.168, <0.001). During the aging process, the proportion of TAO patients with unilateral involvement also gradually decreased (γ=-0.23, <0.001). In addition, the proportion of TAO patients with upper eyelid retraction ≥2mm and exophthalmometry ≥17mm also decreased (γ=-0.158, <0.001, γ=-0.23, <0.001). In comparison to males, females with TAO showed a higher proportion of unilateral eye involvement and upper eyelid retraction ≥2mm (=0.038, <0.001). However, males had a higher proportion of exophthalmometry ≥17mm (<0.001). The proportions of patients with eye movement disorder (γ=0.535, <0.001), diplopia (γ=0.446, <0.001), intraocular pressure (IOP) ≥30mmHg (γ=0.149, <0.001), sight-threatening TAO (γ=0.479, <0.001), and active TAO (γ=0.469, <0.001) were positively correlated with age in TAO patients. Additionally, the proportion of male patients is higher than that of female patients.
TAO Patients exhibit different clinical features depending on age and gender. In elderly and male patients, TAO tends to be more severe, with a higher prevalence of eye muscle involvement, IOP ≥30mmHg, active phases, and a lower proportion of patients with upper eyelid retraction ≥2mm. Elderly female patients also have a lower proportion of exophthalmometry ≥17mm.
甲状腺相关眼病(TAO)的临床表现存在显著的个体差异。年龄和性别会影响 TAO 的表现和严重程度。
评估 TAO 患者的临床特征,特别考虑其年龄和性别。
收集了 2479 例 TAO 患者的人口统计学和临床数据。患者根据年龄分为 7 组:组 1:≤18 岁;组 2:19-29 岁;组 3:30-39 岁;组 4:40-49 岁;组 5:50-59 岁;组 6:60-69 岁;组 7:≥70 岁。比较不同组之间以及男性和女性之间的临床表现。
在年龄组 1 中,女性 TAO 患者与男性患者的比例为 3.79,而在年龄组 7 中,这一比例为 0.86。随着年龄的增长,女性的比例下降(γ=-0.168,<0.001)。在衰老过程中,单侧受累的 TAO 患者比例也逐渐下降(γ=-0.23,<0.001)。此外,上睑退缩≥2mm 和眼球突出度≥17mm 的 TAO 患者比例也下降(γ=-0.158,<0.001,γ=-0.23,<0.001)。与男性相比,女性 TAO 患者单侧眼受累和上睑退缩≥2mm 的比例更高(=0.038,<0.001)。然而,男性眼球突出度≥17mm 的比例更高(<0.001)。眼球运动障碍(γ=0.535,<0.001)、复视(γ=0.446,<0.001)、眼压(IOP)≥30mmHg(γ=0.149,<0.001)、威胁视力的 TAO(γ=0.479,<0.001)和活动期 TAO(γ=0.469,<0.001)的比例与 TAO 患者的年龄呈正相关。此外,男性患者的比例高于女性患者。
TAO 患者的临床表现因年龄和性别而异。在老年和男性患者中,TAO 往往更严重,眼外肌受累、IOP≥30mmHg、活动期和上睑退缩≥2mm 的患者比例较高,而女性患者的上睑退缩≥2mm 的比例较低。老年女性患者的眼球突出度≥17mm 的比例也较低。